Mankind Pharma shares Q2 and H1 FY27 earnings call recording

Investor Communications View source PDF Explain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+8.2%Reaction day

₹2312.00

prior close

₹2358.50

announcement price

After-mkt

timing

Nifty Midcap 150marketpendingvs market: pending

Pharmaceuticals peers, median of 173sector+2.0%+6.3% vs sector

On the reaction day the stock moved 6.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.6

10m

+3.3

15m

+3.7

30m

+5.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+8.2pendingpending+2.0+6.3

Next day

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mankind Pharma informed the exchanges that the audio recording of its October 26, 2026 earnings conference call for Q2 and H1 FY27 is available. The filing provides only a link and does not disclose financial figures or forward guidance in the text.

Likely market impact

The filing gives no financial details; investors should review the recording for performance updates and the outlook.